Professor of Medicine, University Fla College of Medicine
Oncology
Dr. John R. Wingard, MD
|
|
Give Review
John Wingard works in the field of Oncology. He went to medical school at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He over the years received 3 awards: "America's Top Doctors", "America's Top Doctors for Cancer" and "Top Doctors: Florida". Doctor John R. Wingard, MD is a published doctor as well. He has 99 publications published. The latest was: Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor Cells.
- Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis.
- Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
- Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.
- Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.
- Secondary solid Cancer screening following hematopoietic cell transplantation.
- Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor Cells from unrelated donors, a Center for Inter...
- Effect of Cord Blood Processing on Transplant Outcomes after Single Myeloablative Umbilical Cord Blood Transplantation.
- Reply to "insufficient demonstration of long-term stability of Aspergillus galactomannan".
- Alternative donors extend transplantation for patients with Lymphoma who lack an HLA matched donor.
- Update on epidemiology of and preventive strategies for invasive fungal infections in Cancer patients.
- Exercise and Stress Management Training Prior to Hematopoietic Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902.
- Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014.
- Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem Cell transplant survivors.
- Second solid Cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning.
- Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome af...
- Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines of the American Society for Blood and Marrow...
- Elevated incidence of Chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients.
- Long-term stability at -20{degrees} C of Aspergillus GM in serum and bronchoalveolar lavage specimens.
- Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.
- Clinical guide to fertility preservation in hematopoietic Cell transplant recipients.
- Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guid...
- Continuous infusion cyclophosphamide and low-dose total body irradiation is a safe and effective conditioning regimen for autologous transplant in multiple Myeloma.
- Health-related Quality of Life of Bone Marrow versus Peripheral Blood Stem Cell Donors: A Prespecified Subgroup Analysis from a Phase III RCT-BMTCTN Protocol 0201.
- Aztreonam for febrile Neutropenia in patients with beta-lactam allergy.
- Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem Cell transplant recipients.
- Umbilical cord blood Graft enhancement strategies: has the time come to move these into the clinic?
- Autologous Umbilical Cord Blood (UCB) Infusion Followed by Oral Docosahexanoic Acid (DHA) and Vitamin D (VitD) Supplementation for C-Peptide Preservation in Children w...
- Development and Evaluation of a Calibrator Material for Nucleic Acid-based Assays for Diagnosing Aspergillosis.
- Second malignancies after autologous hematopoietic Cell transplantation in children.
- Physician perceptions and practice patterns regarding fertility preservation in hematopoietic Cell transplant recipients.
- Extramedullary Disease in plasma cell myeloma: the iceberg phenomenon.
- Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
- Diagnostic methods for invasive fungal Diseases in patients with hematologic malignancies.
- Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in Acute leukemia and transplantation?
- Peripheral-blood stem Cells versus bone marrow from unrelated donors.
- No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic Cell transplantation.
- Armed Killers Face Off against Cytomegalovirus.
- How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic Cell transplantation.
- Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-Cell transplantation.
- Use of antibacterial prophylaxis in patients with chemotherapy-induced Neutropenia.
- Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with Leukemia and myelodysplastic syndromes.
- Autologous Umbilical Cord Blood Transfusion in Young Children With Type 1 Diabetes Fails to Preserve C-Peptide.
- Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
- Assessing responses to treatment of opportunistic mycoses and salvage strategies.
- Risk factors associated with increased non-relapse mortality and with poor overall survival in children with Chronic graft-versus-host disease.
- African American adult apheresis donors respond to granulocyte-colony-stimulating factor with neutrophil and progenitor Cell yields comparable to those of Caucasian an...
- Malignancies after hematopoietic Cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research.
- Pandemic influenza: was the concern warranted?
- Alternative donor transplantation: results of parallel phase II trials using HLA-mismatched related bone marrow or unrelated umbilical cord blood Grafts.
- Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
- Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation.
- Generic immunosuppressants in hematopoietic Cell transplantation.
- Hematopoietic stem Cell transplantation: an overview of infection risks and epidemiology.
- Pregnancy after hematopoietic Cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Resear...
- Secondary solid Cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.
- Factors associated with self-reported physical and mental health after hematopoietic Cell transplantation.
- Galactomannan Testing in Bronchoalveolar Lavage Fluid Facilitates the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies and Stem ...
- Comparison of lasting life changes after Cancer and BMT: perspectives of long-term survivors and spouses.
- Spiritual absence and 1-year mortality after hematopoietic stem Cell transplant.
- Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.
- Factors associated with mortality in transplant patients with invasive aspergillosis.
- Prospective surveillance for invasive fungal infections in hematopoietic stem Cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Su...
- Serological profiling of a Candida albicans protein microarray reveals permanent Host-pathogen interplay and stage-specific responses during candidemia.
- The preventive health behaviors of long-term survivors of Cancer and hematopoietic stem cell transplantation compared with matched controls.
- The National Marrow Donor Program's symposium on patient advocacy in Cellular transplantation therapy: addressing barriers to hematopoietic Cell transplantation.
- Hypomethylating agent induction therapy followed by hematopoietic Cell transplantation is feasible in patients with myelodysplastic syndromes.
- Autologous umbilical cord blood transfusion in very young children with type 1 diabetes.
- Evaluation of mycophenolate mofetil for initial treatment of Chronic graft-versus-host disease.
- The graft-versus-Leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
- Solid Cancers after allogeneic hematopoietic cell transplantation.
- Combination antifungal therapy: from bench to bedside.
- Defining responses to therapy and study outcomes in clinical trials of invasive fungal Diseases: Mycoses Study Group and European Organization for Research and Treatme...
- Changes in causes of death over time after treatment for invasive aspergillosis.
- Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis.
- Learning from our failures: the antifungal treatment conundrum.
- Transplanted human cord blood cells generate amylase-producing pancreatic acinar cells in enGrafted mice.
- Influenza: preparedness for an inevitable "Emergency" for oncology and BMT units.
- Peripheral blood grafts from unrelated donors are associated with increased Acute and chronic graft-versus-host disease without improved survival.
- The role of the donor in the repair of the marrow vascular niche following hematopoietic stem Cell transplant.
- Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised Hosts.
- Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.
- Late effects of Cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls.
- Spatial distribution of blood vessels and CD34+ hematopoietic stem and progenitor Cells within the marrow cavities of human canCellous bone.
- Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.
- Imaging findings in Acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
- Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal the...
- Umbilical cord blood produces small megakaryocytes after transplantation.
- Prevention and early treatment of invasive fungal infection in patients with Cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-sp...
- Preparing for the unthinkable: emergency preparedness for the hematopoietic Cell transplant program.
- Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.
- Factors associated with parameters of enGraftment potential of umbilical cord blood.
- Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-Cell transplant recipients?
- Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic...
- Recommended screening and preventive practices for long-term survivors after hematopoietic Cell transplantation: joint recommendations of the European Group for Blood ...
- National Institutes of Health consensus development project on criteria for clinical trials in Chronic graft-versus-host disease: I. Diagnosis and staging working grou...
- Interleukin 12 is associated with reduced relapse without increased incidence of Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
- Developmental differences in megakaryocyte maturation are determined by the microenvironment.
Schools
Johns Hopkins University School of Medicine
Memphis City Hosps
VA Hospital
Johns Hopkins Hospital
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Breast Cancer
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Top Doctors: Florida
Education
-
Johns Hopkins University -
University of Tennessee -
Johns Hopkins University School of Medicine
Hospital
-
UF Health Shands Hospital
Drug Facts
| NPI NUMBER | 1700818150 | |
| NPPES Provider LastName | WINGARD | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 326103003 | |
| NPPES Provider State | FL | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 220.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700818150 |
| Last Name Of The Provider | WINGARD |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Peter I. Acs, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carmen J. Allegra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Long H. Dang, MD |
|
|
Dr. Jennifer M. Duff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Coy D. Heldermon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Hiemenz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles E. Riggs Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nam H. Dang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Merry J. Markham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Priya K. Gopalan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Farrugia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellen A. Szwed, DO |